Skip to content

ISTA PHARMACEUTICALS INC

CIK 0000930553

← back to feed
Revenue (TTM)
$149.26M
+2.4% YoY Q1 Mar 2012
Net Income (TTM)
−$58.49M
−968.0% YoY Q1 Mar 2012
EPS Diluted (TTM)
$0.80
Q1 Mar 2012
Gross Margin
82.5%
Q1 Mar 2012
Operating Margin
-7.8%
Q1 Mar 2012
Net Margin
-39.2%
Q1 Mar 2012
Free Cash Flow (TTM)
−$5.4M
Q1 Mar 2012
Cash
$53.69M
Q1 Mar 2012
Total Debt
—
Q1 Mar 2012
Shares Outstanding
41.91M sh
Q1 Mar 2012

Revenue & Net Income

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings